港股开盘：恒指涨0.23%、科指涨0.21%，AI应用概念股延续强势，科网股及创新药概念股活跃

Market Overview - The Hong Kong stock market opened higher with the Hang Seng Index rising by 0.23% to 27,246.18 points, the Hang Seng Tech Index up by 0.21% to 5,462.7 points, and the National Enterprises Index increasing by 0.17% to 9,258.27 points, indicating a mixed trading environment near key technical levels [1] Blue Chip Performance - Semiconductor company SMIC reported a significant increase in capacity utilization, reaching 93.5% in 2025, an 8 percentage point increase year-on-year, with projected sales revenue of $9.327 billion, a 16.2% increase, and net profit of $685 million, up 39.1% [2] - PCCW expects a revenue growth of 7% to HKD 40.252 billion in 2025, with EBITDA increasing by 3% and losses narrowing by 16% [2] - Television Broadcasts Limited anticipates turning a profit, while Dongyue Group expects profit growth of over 100% [2] Consumer and Real Estate Sector Challenges - Bosideng International reported a 32.5% year-on-year decline in net operating income for January, while Yue Yuen Industrial saw a 12.5% decrease [3] - The real estate sector is under pressure, with New World Development announcing a 29.79% year-on-year drop in contract sales for January, and Yuzhou Group reporting a slight increase of 5.79%, but market skepticism about overall industry recovery persists [3] Company Developments - Minth Group announced a joint venture with Aisin and Toyota to produce aluminum vehicle body components, aiming to strengthen its supply chain in the North American market [4] - Stone Four Pharmaceutical Group plans to participate in the eighth batch of national centralized procurement with 45 products across various treatment areas [5] - Gilead Sciences completed a placement raising approximately HKD 835 million, with 90% allocated for global Phase III clinical trials of an oral GLP-1 receptor agonist for obesity [5] Institutional Insights - Industrial Securities noted that the ongoing loose overseas liquidity environment and expectations of interest rate cuts by the Federal Reserve could lead to foreign capital inflows into Hong Kong stocks in 2026 [6] - The recent stabilization in Hong Kong stocks, particularly in the Hang Seng Tech sector, suggests potential for valuation recovery and performance realization in AI, innovative pharmaceuticals, and high-dividend sectors [6] - Guotai Junan Securities highlighted the potential for a phase of upward movement in Hong Kong stocks around the Lunar New Year, with increased correlation to A-shares [6] Focus on Innovative Pharmaceuticals - Open Source Securities expressed optimism about the innovative pharmaceutical sector, noting that the total value of License-out transactions has exceeded last year's figures, and the quality of China's innovative drug pipeline is improving [7]